1. Home
  2. Stocks
  3. Nureca Share Price
  • Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Nureca Share Price

    Small Cap
    ₹356.4
    + 21.8 (6.52%)
    18 September, 2024 02:47 BSE: 543264 NSE: NURECA ISIN: INE0DSF01015

    Start SIP in Nureca

    Start SIP

    Nureca Performance

    Day Range

    • Low 329
    • High 375
    ₹ 356

    52 Week Range

    • Low 240
    • High 469
    ₹ 356
    • Open Price335
    • Previous Close335
    • Volume466226

    Nureca Chart

    • Over 1 Month + 35.87%
    • Over 3 Month + 27.33%
    • Over 6 Month + 14.51%
    • Over 1 Year -1.27%

    Nureca Key Statistics

    P/E Ratio 619.8
    PEG Ratio 5.5
    Market Cap Cr
    Price to Book Ratio 1.8
    EPS -2.2
    Dividend 0
    Relative Strength Index 71.77
    Money Flow Index 87.48
    MACD Signal 15
    Average True Range 17.45

    Nureca Investment Rating

    • Master Rating:

    • Nureca has an operating revenue of Rs. 90.97 Cr. on a trailing 12-month basis. An annual revenue de-growth of -14% needs improvement, Pre-tax margin of -3% needs improvement, ROE of -0% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 17% and 6% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 28 which is a POOR score indicating inconsistency in earnings, a RS Rating of 28 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 126 indicates it belongs to a poor industry group of Medical-Products and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Nureca Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 232022312121
    Operating Expenses Qtr Cr 262427302425
    Operating Profit Qtr Cr -3-5-41-3-4
    Depreciation Qtr Cr 111111
    Interest Qtr Cr 000000
    Tax Qtr Cr 1-21100
    Net Profit Qtr Cr 1-403-1-2
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 105119
    Operating Expenses Annual Cr 106127
    Operating Profit Annual in Cr -11-15
    Depreciation Cr 22
    Interest Annual Cr 00
    Tax Annual Cr -1-3
    Net Profit Annual Cr -2-8
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -312
    Cash from Investing Activity Annual Cr 18-18
    Cash from Financing Annual Activity Cr -1-2
    Net Cash Flow Annual Cr 14-8
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 193195
    Fixed Assets Annual Cr 68
    Total Non Current Assets Annual Cr 1523
    Total Current Assets Annual Cr 189184
    Total Assets Annual Cr 204207
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 193195
    ROE Annual % -1-4
    ROCE Annual % -1-5
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % -1-7
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 201722312121
    Operating Expenses Qtr Cr 232127302425
    Operating Profit Qtr Cr -2-4-41-3-3
    Depreciation Qtr Cr 111111
    Interest Qtr Cr 000000
    Tax Qtr Cr 1-21100
    Net Profit Qtr Cr 2-403-1-2
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 102118
    Operating Expenses Annual Cr 102126
    Operating Profit Annual in Cr -10-15
    Depreciation Cr 22
    Interest Annual Cr 00
    Tax Annual Cr -1-2
    Net Profit Annual Cr -2-8
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -310
    Cash from Investing Activity Annual Cr 18-16
    Cash from Financing Annual Activity Cr -1-2
    Net Cash Flow Annual Cr 14-8
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 193195
    Fixed Assets Annual Cr 79
    Total Non Current Assets Annual Cr 1320
    Total Current Assets Annual Cr 193187
    Total Assets Annual Cr 205207
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 193195
    ROE Annual % -1-4
    ROCE Annual % -1-5
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 0-7
    Invest in Nureca

    Nureca Technicals

    EMA & SMA

    Current Price
    ₹356.4
    + 21.8 (6.52%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹319.78
    • 50 Day
    • ₹299.41
    • 100 Day
    • ₹295.31
    • 200 Day
    • ₹314.86
    • 20 Day
    • ₹317.76
    • 50 Day
    • ₹288.87
    • 100 Day
    • ₹281.48
    • 200 Day
    • ₹315.89

    Nureca Resistance and Support

    PIVOT
    ₹353.45
    Resistance
    First Resistance 377.95
    Second Resistance 399.50
    Third Resistance 424.00
    RSI 71.77
    MFI 87.48
    MACD Single Line 15.00
    MACD 17.01
    Support
    First Support 331.90
    Second Support 307.40
    Third Supoort 285.85

    Nureca Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 504,843 15,503,729 30.71
    Week 134,327 5,010,390 37.3
    1 Month 154,610 5,994,237 38.77
    6 Month 52,948 2,427,684 45.85

    Nureca Result Highlights

    Nureca Synopsis

    NSE-Medical-Products

    Nureca Ltd is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 94.52 Cr. and Equity Capital is Rs. 10.00 Cr. for the Year ended 31/03/2024. Nureca Ltd. is a Public Limited Listed company incorporated on 02/11/2016 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24304MH2016PLC320868 and registration number is 320868.
    Market Cap 335
    Sales 97
    Shares in Float 0.37
    No of funds 2
    Yield 1
    Book Value 1.73
    U/D Vol ratio 4
    LTDebt / Equity
    Alpha -0.11
    Beta 0.94

    Nureca Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 63.24%63.24%63.24%63.24%
    Foreign Portfolio Investors 0.07%0.07%0.07%0.1%
    Individual Investors 34.24%33.73%33.61%34.32%
    Others 2.45%2.96%3.08%2.34%

    Nureca Management

    Name Designation
    Mr. Saurabh Goyal Chairman & Managing Director
    Mr. Aryan Goyal WholeTime Director & CEO
    Mr. Rajinder Sharma Whole Time Director
    Ms. Charu Singh Independent Director
    Ms. Ruchita Agarwal Independent Director
    Mr. Vijay Kumar Sharma Independent Director
    Dr. Vikram Chaudhery Independent Director

    Nureca Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Nureca Corporate Action

    Date Purpose Remarks
    2024-08-05 Quarterly Results
    2024-05-15 Audited Results
    2024-02-07 Quarterly Results
    2023-11-04 Quarterly Results
    2023-08-10 Quarterly Results
    Date Purpose Remarks
    2022-02-25 INTERIM Rs.3.00 per share(30%)Interim Dividend

    Nureca MF Shareholding

    Name Amount(cr)

    Nureca FAQs

    What is Share Price of Nureca ?

    Nureca share price is ₹356 As on 18 September, 2024 | 02:33

    What is the Market Cap of Nureca ?

    The Market Cap of Nureca is ₹356.4 Cr As on 18 September, 2024 | 02:33

    What is the P/E ratio of Nureca ?

    The P/E ratio of Nureca is 619.8 As on 18 September, 2024 | 02:33

    What is the PB ratio of Nureca ?

    The PB ratio of Nureca is 1.8 As on 18 September, 2024 | 02:33

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     
    footer_form

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 29/07/2024 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.